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1. Introduction  
Many investigations have been conducted on soybean during the past decade since it is a 
unique dietary source of isoflavones which display a diversity of biological activities and 
reduce the risk of some chronic diseases. Soybean is distinctive in that it has a high content 
of isoflavones which allegedly diminish the risk of cancer, cardiovascular disease, and 
osteoporosis, and also alleviate menopausal symptoms. Isoflavones are weakly estrogenic. 
The isoflavone genistein also affects signal transduction. Soyfoods and isoflavones have 
arrested the attention of many researchers on account of their potential role in preventing 
and treating cancer and osteoporosis. The low breast cancer mortality rates in Asia and the 
putative antiestrogenic infer that soyfood intake reduces breast cancer risk. Soy or 
isoflavones may decrease the risk of prostate cancer. The low estrogenic activity of soybean 
isoflavones and their structural resemblance to the synthetic isoflavone ipriflavone, which 
elevates bone mineral density in postmenopausal women, suggest that soy or isoflavones 
may decrease the risk of osteoporosis.  
Besides isoflavones, soybean also produces protease inhibitors, lectins, and antifungal 
proteins, which have important biological activities. This review encompasses a discussion 
of isoflavones, protease inhibitors, lectins and antifungal proteins. 
2. Protease inhibitors 
Protease inhibitors in soybeans can reduce protein digestion, and induce pancreatomegaly 
and enhance chemically induced pancreatic tumors in some animals (Grant, 1989). The 
quantity of protease inhibitors ingested would not have any adverse consequences in 
humans (Liener, 1994). The trypsin / chymotrypsin inhibitor (Bowman-Birk inhibitor) found 
in soybeans has been studied as an anticancer agent (Kennedy, 1995). 
A large number of protease inhibitors belonging to various types have been purified from 
different kinds of legumes. In the study of Fang et al. (2010b), by using liquid 
chromatography techniques, a Kunitz type trypsin inhibitor (KBTI) was isolated from 
Korean large black soybeans. It exhibited a molecular mass of 20107.645 Da and inhibited 
the proteases trypsin and alpha-chymotrypsin with an activity of 8520 BAEE units/mg and 
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24 BTEE units/mg, respectively. Its trypsin inhibitory activity demonstrated pronounced 
thermal stability (0-100 oC) and stability over a wide range of pH values (pH 3-11). KBTI 
reduced the activity of HIV-1 reverse transcriptase activity with an IC50 value of 0.71 μM. It 
evoked the release of pro-inflammatory cytokines including TNF-alpha, IL-1beta, IL-2 and 
interferon-gamma at the mRNA level. KBTI exerted low antiproliferative activity toward 
CNE-2 and HNE-2 nasopharyngeal cancer cells, MCF-7 breast cancer cells, and Hep G2 
hepatoma cells. It was devoid of mitogenic, ribonuclease and antifungal activities. 
A 19-kDa trypsin inhibitor with an N-terminal amino acid sequence highly homologous to 
Kunitz-type trypsin inhibitors was purified from seeds of Chinese black soybean Glycine 
max cv. "Small Glossy Black" using a procedure that involved anion exchange 
chromatography on Q-Sepharose, cation exchange chromatography on SP-Sepharose and 
anion exchanger chromatography on DEAE-cellulose. It was bound on all three ion 
exchangers. It inhibited trypsin with an IC50 of 19 μM and chymotrypsin with an IC50 of 14.3 
μM. Its trypsin inhibitory activity was relatively pH stable and thermostable. It was 
preserved in the pH range pH 3-pH 13 and in the temperature range 0 oC-60 oC. The trypsin 
inhibitory activity was reduced in the presence of dithiothreitol (from 5 to 25 mM) in a dose-
dependent manner indicating the paramount importance of disulphide bonds to the 
activity. It inhibited HIV-1 reverse transcriptase with an IC50 of 0.16 μM, and exerted 
antiproliferative activity toward MCF-7 breast cancer cells with an IC50 of 4.3 μM and 
HepG2 hepatoma cells with an IC50 higher than 25 μM. The trypsin inhibitor was devoid of 
antifungal activity and mitogenic activity towards mouse splenocytes (Ye and Ng, 2009a). 
A trypsin inhibitor from the seeds of Hokkaido large black soybeans possessed an N-
terminal amino acid sequence that closely resembled those of 8-kDa Bowman-Birk trypsin 
inhibitors. The trypsin inhibitor was unbound on SP-Sepharose but bound on the anion 
exchangers DEAE-cellulose and Mono Q. It exerted antiproliferative activity toward breast 
cancer (MCF-7) cells and hepatoma (HepG2) cells with an IC50 of 35 and 140 μM, 
respectively. The trypsin inhibitory activity of the inhibitor was retained following thermal 
treatment up to 100 oC for 30 min and after exposure to the pH range 2-13 for the same 
duration. The trypsin inhibitor inhibited HIV-1 reverse transcriptase with an IC50 of 38 μM. 
Moreover, there was no antifungal activity toward Fusarium oxysporum and Mycosphaerella 
arachidicola (Ho and Ng, 2008). 
Chinese ‘Large Black Soybeans’ produce a 60-kDa lectin and a 20 kDa trypsin inhibitor. Both 
proteins were absorbed on Q-Sepharose, but could be separated from one another on Mono 
Q. Further purification was achieved by gel filtration on Superdex 75. Both trypsin inhibitor 
and lectin were stable from pH 3 to 13 and from 0 oC to 65 oC. The trypsin inhibitor was 
stable at pH as low as 2, and it inhibited trypsin and chrymotrypsin with an IC50 of 5.7 μM 
and 5 μM, respectively. Its trypsin inhibitory activity was reduced in the presence of 
dithiothreitol indicating the importance of the disulphide bond to the activity. Both trypsin 
inhibitor and lectin inhibited HIV-1 reverse transcriptase (IC50 = 44 and 26 μM) and 
proliferation of HepG2 hepatoma cells (IC50 =9 6 and 17 μM) and MCF7 breast cancer cells 
(IC50 = 42 and 13.5 μM) (Ye and Ng, 2009b).  
Studies utilizing different types of protease inhibitors as anticarcinogenic agents in vivo and 
in vitro systems have recently been reviewed. These studies suggest that the protease 
inhibitors which prevent carcinogenesis affect processes in the early stages of 
carcinogenesis, although they can be effective at long time periods after carcinogen exposure 
in both in vitro and in vivo systems. While there is strong evidence that these protease 
inhibitors can affect both the initiation and promotion stages of carcinogenesis, they have no 
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effect on already transformed cells. The results have suggested that the first event in 
carcinogenesis is a high frequency epigenetic event and that a later event, presumably 
genetic, leads to the malignant state. Protease inhibitors appear capable of reversing the 
initiating event, presumably by stopping an ongoing cellular process begun by carcinogen 
exposure. The major lines of investigation on the mechanism of the protease inhibitor 
suppression of carcinogenesis relate to the ability of anticarcinogenic protease inhibitors to 
affect the expression of certain oncogenes, and the levels of certain types of proteolytic 
activities. The anticarcinogenic protease inhibitors have no observable effects on normal 
cells, but can reverse carcinogen-induced cellular changes for several different end-points 
studied. The most direct method of determining the mechanism of action of the 
anticarcinogenic protease inhibitors is to identify and characterize the proteases with which 
they interact. In the cells of the in vivo and in vitro systems in which protease inhibitors can 
prevent carcinogenesis, only a few proteases have been observed to interact with the 
anticarcinogenic protease inhibitors. Proteases have been identified by both substrate 
hydrolysis and affinity chromatography (Kennedy, 1995). 
3. Lectins 
Lectins, a class of proteins that reversibly and non-enzymatically bind specific sugars, have 
been purified from different kinds of legumes. In the study of Fang et al. (2010a), a lectin 
(KBL) with a molecular mass of 48 kDa was isolated from Korean large black soybeans. The 
specific hemagglutinating activity of the lectin was 4096 titer/mg. The metal chelator EDTA 
brought about a decline of hemagglutinating activity. The activity could be reinstated by 
addition of Fe3+ ions and divalent cations such as Ca2+, Mn2+, Fe2+, Cu2+, Zn2+, and Pb2+. The 
lectin was specific to sugars including D-(+)-galactose, D-(+)-raffinose, L-(+)-arabinose, 
alpha-D-(+)-melibiose, and alpha-lactose, the hemagglutinating activity of the lectin could 
be inhibited by these sugars. The lectin manifested remarkable thermal stability and stability 
over a wide range of pH values. The lectin demonstrated HIV-1 reverse transcriptase 
inhibitory activity with an IC50 of 1.38 μM. However, it lacked antifungal, cytokine inducing, 
mitogenic and ribonuclease activities. In addition, it did not inhibit proliferation of 
nasopharyngeal cell lines at concentrations up to 20 μM. 
A lectin was purified from the seeds of the cultivar of soybean (Glycine max), called the small 
glossy black soybean. The purification protocol involved anion exchange chromatography 
on Q Sepharose, cation exchange chromatography on SP Sepharose and fast protein liquid 
chromatography anion exchange chromatography on Mono Q followed by gel filtration on 
Superdex 75. The dimeric 50 kDa melibiose-binding lectin with an N-terminal sequence 
identical to that of soybean lectin was bound on all three ion exchangers. Of all the sugars 
tested, melibiose most potently inhibited the hemagglutinating activity of the lectin. The 
lectin was stable between pH 3-12 and 0-70 oC. The lectin elicited maximal mitogenic 
response from murine splenocytes at about the same molar concentration as Con A. 
Although the magnitude of the maximal response was smaller, the soybean lectin 
suppressed the activity of HIV-1 reverse transcriptase and exerted antiproliferative activity 
toward breast cancer MCF7 cells and hepatoma HepG2 cells with an IC50 of 2.82 μM, 2.6 μM 
and 4.1 μM, respectively. The lectin lacked antifungal activity. Another lectin isolated from a 
different cultivar of soybean called little black soybean was grossly similar to small glossy 
black soybean lectin but the former had a larger subunit molecular mass (31 kDa), a more 
potent mitogenic activity and lower thermostability. The data suggest that different soybean 
cultivars produce similar but not identical lectins (Lin et al., 2008). 
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4. Antifungal proteins 
A 25 kDa monomeric antifungal protein with an N-terminal amino acid sequence exhibiting  
homology to a segment of chitin synthase, was purified from the seeds of the black soybean 
Glycine soja. The protein was designated as glysojanin. It potently inhibited mycelial growth 
of the fungi Fusarium oxysporum and Mycosphaerella arachidicola. It inhibited HIV-1 reverse 
transcriptase with an IC50 of 47 μM, [methyl-3H]thymidine incorporation by mouse 
splenocytes with an IC50 of 175 μM, and 3H-leucine incorporation into proteins in the cell-
free rabbit reticulocyte lysate with an IC50 of 20 μM. The isolation protocol involved anion-
exchange chromatography on DEAE-cellulose, affinity chromatography on Affi-gel blue gel, 
cation-exchange chromatography by fast protein liquid chromatography on Mono S, and gel 
filtration by fast protein liquid chromatography on Superdex 75 (Ngai and Ng, 2008). 
5. Saponins 
Saponins are glycosides composed of a lipid-soluble aglycone consisting of either a sterol or, 
more often, a triterpenoid structure linked to water-soluble sugar residues that vary in their 
type and quantity. Legumes are the major sources of dietary saponins. The same bean can 
have different types of saponins. Saponins are very poorly absorbed. Most saponins form 
insoluble complexes with 3-ǃ-hydroxysteroids and interact with and form large, mixed 
micelles with bile acids and cholesterol. Although saponins were shown to lower cholesterol 
in some animal species, the hypocholesterolemic effects of saponins in humans are more 
speculative (Milgate and Roberts, 1995). Saponins may have anticancer properties, as 
suggested by a recent rodent study that found that a saponin-containing diet (3% by wt) 
inhibited by about two-thirds the development of azoxymethane-induced preneoplastic 
lesions in the colon (Koratkar and Rao, 1997). However, given that human intake of 
saponins is generally 200–300 mg/d whereas total food intake is <500 g (dry weight), it is 
not clear to what extent these results in rodents are relevant to humans (Ridout et al., 1988). 
The effect of saponins isolated from soya bean flour on the incidence of aberrant crypt foci 
(ACF) induced by azoxymethane (AOM) in the colonic wall of CF1 mice was investigated. 
Four weekly injections of AOM, a known colon carcinogen, were administered to mice. One 
week after the last injection, mice were placed on an AIN-76 diet supplemented with 3% 
soya bean saponins or continued on the basal AIN-76 diet. Another group of mice was 
placed on the saponin diet without AOM initiation to observe the effect of saponins on the 
growth characteristics of mice. Dietary intake of soya saponins significantly reduced the 
incidence of ACF at the end of 14 weeks (postinitiation). Noninitiated mice maintained on a 
similar soya bean saponin-supplemented diet did not show any adverse effects on the 
growth and overall health of the animals. These findings suggest that soya bean saponins 
can play an important role in inhibiting the incidence of ACF in the colon of mice (Koratkar 
and Rao, 1997). 
Daidzein, an isoflavone in soybeans, suppresses the growth of HL-60 cells implanted in 
mouse subrenal capsules (Jing et al., 1993). Genistein inhibits the proliferation of a diversity 
of both hormone-dependent and hormone-independent cancer cells in vitro with an IC50 
between 5 and 40 mM (2–10 mg/mL), including breast (Peterson and Barnes, 1991; 1996; 
Pagliacci et al., 1994; Peterson et al., 1996; So et al., 1996; Clark et al., 1996; Zava and Duwe, 
1997), prostate (Peterson and Barnes, 1993; Naik et al., 1994;  Kyle et al., 1997), colon (Kuo et 
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al., 1997; Kuo, 1996), and skin (Rauth et al., 1997) cancer cells (Adlercreutz and Mazur, 1997; 
Akiyama and Ogawara, 1991; Constantinou and Huberman 1995). Genistein suppresses the 
metastatic activity of breast (Scholar and Toewa, 1994) and prostate (Santibáñez et al., 1997) 
cancer cells in vitro independent of the effects on cell growth. The anticancer effects of 
genistein in vitro (Wei et al., 1993) are attributed to its inhibitory effects on enzymes that 
play a role in signal transduction, including ribosomal S6 kinase (Linassier et al., 1990), MAP 
kinase (Thorburn and Thorburn, 1994), and tyrosine protein kinases (Akiyama et al., 1987). 
Genistein also inhibits the activity of DNA topoisomerase II (Constantinou et al., 1990) and 
raises the in vitro concentrations of transforming growth factor ǃ (TGF ǃ) (Peterson et al., 
1998) which may suppress growth of cancer cells (Benson and Colletta, 1995; Benson et al., 
1996; Markowitz and Roberts, 1997). Genistein has an important role as a potent inhibitor of 
angiogenesis in vitro (Messina, 1999). 
Genistein exerts an inhibitory action on the growth of both estrogen-dependent and 
estrogen-independent breast cancer cells in vitro, but it is not certain if cellular 
concentrations of genistein in vivo can  reach  in vitro concentration  capable of  suppressing 
growth of breast cancer cells. Genistein inhibits proliferation of  induced serum and 
epidermal growth factor–stimulated normal human mammary epithelial cells with IC50 
values substantially  lower than those for transformed human breast epithelial cells 
(Peterson and Barnes, 1994) suggesting that soy intake may inhibit the initiation of cancer 
cells, rather than impeding the proliferation of existing cancer cells. Because synergistic 
effects between genistein and daidzein have been observed in vitro, it would be of interest to 
examine their concerted action in vivo (Evans et al., 1995; Franke et al., 1995). The possibility 
remains that other components of soybeans, individually or in conjunction with isoflavones, 
account for the hypothesized anticancer effects of soyfoods. Wrensch et al (1991), 
McMichael-Phillips et al (1998), and Cassidy et al (1994; 1995) demonstrated that soy or 
isoflavones are potentially capable of producing physiological actions related to breast 
cancer risk. Cassidy et al (1994) noticed that the intake of soy, in particular isoflavone-rich 
soy (Cassidy et al., 1995), prolongs the follicular phase and circulation levels of 
gonadotropins. Brown and Lamartiniere (1995), Lamartiniere et al (1995), and Murrill et al 
(1996) were of the opinion that early consumption of soyfoods by young girls may prevent 
breast cancer development later in life. Neonatal or prepubertal exposure to genistein 
inhibits the development of dimethylbenz(a) anthracene-induced mammary tumors in 
rodents and prolongs the latency period (Brown and Lamartiniere, 1995; Lamartiniere et al., 
1995; Murrill et al 1996).  
Genistein exerts and antiproliferative action on both androgen-dependent and androgen-
independent prostate cancer cells in vitro (Peterson and Barnes, 1993; Naik et al., 1994). It 
also diminishes the potential of prostate cancer cells to metastasise independent of cell 
growth inhibition. Concomitantly tyrosine phosphorylation of an unidentified molecular 
species declines (Santibáñez et al., 1997). Though the role played by estrogen in prostate 
cancer has not been clarified, estrogens are effective in the therapy of metastatic prostate 
cancer (Pienta and Esper, 1993). Hence the potential estrogenic effects of isoflavones may be 
protective. Genistein inhibits 5-ǂ-reductase in genital skin fibroblasts and benign 
hyperplastic prostate tissue (Evans et al., 1995). This enzyme converts testosterone into a 
more potent form dihydrotestosterone, which stimulates the growth of prostatic tissue. Ross 
et al (1992) showed that biomarkers of 5-ǂ-reductase activity are higher in white and black 
men compared with Japanese men. The in vitro  results of Evans et al (1995) agree with data 
from Lu et al (1996), showing that following 1 month of soymilk consumption (36 oz/d), the 
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serum concentration of 3ǂ, 17ǃ-androstanediol glucuronide, a dihydrotestosterone 
metabolite, was significantly lowered. In mice fed a diet containing soy for 9 months, the 
incidence of prostatic dysplasia, considered to be a preneoplastic prostate lesion, was 
significantly diminished. At 12 months, however, difference between the 2 groups was 
much attenuated. These results are in line with the epidemiologic data noted above and also 
with the results of a study of MNU-induced prostate tumors in Lobund-Wistar rats (Pollard 
and Luckert, 1997).  
Rats receiving a diet containing soy had a shorter latency period than those fed a diet 
containing soy high in isoflavones with a small quantity of isoflavones (Pollard and Luckert, 
1997). A diet containing soy flour (33% by weight) for 4 months inhibited tumor growth in rats 
with Dunning R3327 PAP tumors implanted (Zhang et al., 1997). Schleicher et al (1998) 
Genistein (50 mg/kg body weight) given to rats subcutaneously in the dorsal scapular area 
every 12 h stranting at the time of tumor cell transplantation inhibited development of 
prostate tumor implanted with prostate cancer cells and totally inhibited development of lung 
metastases. Dalu et al (1998) reported that genistein (1 mg genistein/g diet) caused a decline in 
weight of the dorsolateral and ventral prostates and down-regulated the expression of 
tyrosine-phosphorylated proteins in rats. genistein dose-dependently inhibited 3H-thymidine 
incorporation in cultured benign prostatic hypentrophy tissue and prostate cancer tissue 
(Geller et al., 1998) Although genistein suppressed growth of prostatic cancer cells in vitro, 
when the metastatic MAT-Lylu prostate cancer cells were injected into the right flank of rats, 
oral treatment with genistein did not suppress  the prostate tumors development (Naik et al., 
1994). The doses utilized more closely resembled human dietary intake than those employed 
in the investigations of Schleicher et al (1998) and Dalu et al (1998). Higher doses of genistein 
injected intraperitoneally had little effect on tumor growth (Naik et al., 1994). There are limited 
human data available for use in addressing the soy–prostate cancer hypothesis, although 
Severson et al (1989) noted that tofu consumption might produce a lower risk of prostate 
cancer. Isoflavones are detected in the prostatic fluid, at the highest concentrations in men 
from soyfood-consuming countries (Morton et al., 1997). Isoflavones are concentrated several-
fold in the prostatic fluid compared to plasma concentrations,.  
Genistein inhibits DNA synthesis in human prostate cells in vitro and reduces effect of 
testosterone in prostate cancer development in rats (Jenkins et al., 2003; Adlercreutz et al., 
2000). However, a daily soybean intake sufficient to bring about a decline LDL-cholesterol, 
does not effect  serum concentration of prostate specific antigen (Adlercreutz, 2002). 
Antifungal proteins (Ma et al., 2009) lectins/hemagglutinins (Lin et al., 2008) and protease 
inhibitors (Fang et al., 2010) demonstrate antiproliferative activity toward tumor cells in 
vitro. Some of these show pH stability and thermostability and thus their aforementioned 
activities may be retained in vivo. 
Fotsis et al (1993) observed that genistein at high concentrations interfered with the action of 
bovine microvascular cells to invade collagen gels and form capillary-like structures when 
treated with basic fibroblast growth factor. Antiangiogenic agents by preventing tumor-
stimulated angiogenesis, inhibit tumor growth beyond a size of 1–2 mm and thus from 
becoming clinically insignificant (Folkman and Klagsbrun, (1987). A low genistein 
concentration is required to inhibit angiogenesis in vitro (Adlercreutz and Mazur, 1997). 
The antimetastatic activity of soybean saponin has been examined by assessing matrix 
production of the metalloproteinases MMP-2 and MMP-9 in HT-1080 cells (Kang et al., 
2008). MMP-2 and MMP-9 mRNA expression levels were determined by RT-PCR analysis 
and the levels of secreted MMP-2, MMP-9 and tissue inhibitor of metalloproteinase-2 (TIMP-
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2) were assessed by gelatin zymography and/or ELISA. The invasion of a Matrigel-coated 
membrane by human fibrosarcoma HT-1080 and HT-29 colon cancer cells was determined 
by counting the migrated cells. Exposure of HT-1080 cells to soybean saponin diminished 
the mRNA expression of and attenuated the secretion of MMP-2 and MMP-9. However, the 
secretion of TIMP-2 was enhanced in a dose-dependent manner. The invasion of HT-1080 
cells through a Matrigel-coated membrane was suppressed. The antimetastatic activity of 
soybean saponin was further confirmed in an in vivo mouse experiment in which CT-26 
colon cancer cells were injected via the caudal vein after administering soybean saponin in 
the diet. The incidence of metastatic tumor colonization of lungs in mice underwent a mild 
decline 14 days after injection of CT-26 cells via the caudal vein. Thus, soybean saponin 
reduces tumor cell metastasis by inhibiting production of MMP-2 and MM-9 production and 
enhancing TIMP-2 secretion.  
The structural resemblance between estrogen, isoflavones and the synthetic isoflavone, 7-
isopropoxyisoflavone (ipriflavone), which increases bone mass in postmenopausal women 
(Valente et al., 1994; Brandi, 1992), inhibits osteoclast activity in vitro (Tsude et al., 1986) 
raises speculation about the benfits of isoflavones bone health. The ipriflavone has to be 
metabolized in order to be maximally effective. Daidzein, a soybean isoflavone is one of the 
metabolites.   
That genistein in particular affects bone density in rats (Blair et al., 1996; Fanti et al., 1998). Blair 
et al (1996) observed that the dry femoral mass of ovariectomized rats fed 30 mmol genistein 
in particular /day for 4 weeks was 12% higher (P < 0.05) than that of the controls. In a study 
by Fanti et al (1998), after 21 days of subcutaneous injection of 5 and 25 mg genistein/g body 
wt, tibial bone mineral loss in ovariectomized rats was significantly reduced. Potter et al (1998) 
reported that following 6 months of treatment, lumbar spine bone mineral density was 
significantly increased in postmenopausal women who had a daily intake of 40 g soy protein 
containing 2.25 mg isoflavones/g protein, while bone density remained unchanged in women 
who ingested the same amount of soy protein but containing only 60 % isoflavones (1.39 mg 
isoflavones/g protein). Some insight has been gained into the possible mechanism(s) 
regulating the effect of isoflavones on bone health in rats. Isoflavones may both stimulate and 
inhibit bone formation. Fanti et al (1998) reported that genistein augmented the number of 
osteoblasts and the serum osteocalcin level, but had no effect on  number of osteoclasts.On the 
other hand, Blair et al (1996) noted that genistein inhibited avian osteoclast protein synthesis in 
vitro probably due to its inhibitory effects on tyrosine phosphorylation. Estrogen and 
tamoxifen, which inhibit bone resorption, induce apoptosis in osteoclasts, an effect which is 
antagonized in vitro by antibodies to TGF-ǃ (Hughes et al., 1996). Since genistein enhanced 
TGF-ǃ in vitro, the effect of the isoflavone bone resorption may involve TGF-ǃ. 
The decrease in hepatic cholesterol synthesis is caused by a decrease in serum insulin 
concentration because insulin activates an enzyme involved in cholesterol synthesis and, on 
the other hand, it might be attributed to a change in the hepatic bile acid profile (Mälkki, 2001).  
The isoflavones in diet containing soybean may retard atherosclerotic progression by virtue 
of their inhibitory activity toward LDL oxidation, which evokes a series of events forming 
atherosclerotic plaques. Isoflavones may elicit a cholesterol-lowering action due to 
interaction with estrogenic receptors, and structural similarity between isoflavones in a diet 
containing and their metabolites and estrogens. (Anderson et al., 1999). Various clinical 
studies have disclosed the importance of consumption of soybean protein with its 
isoflavones to achieve a hypocholesterolemic effect (Lichtenstein, 1998; Farriol et al., 2006). 
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The Asian diet is rich in soybean foods compared with the western diet (Craig, 1997). 
Inclusion of isolated soybean protein with isoflavones in the diet of postmenopausal women 
causes a decline in the incidence of hot flashes (Albertazzi et al., 1998; Setchell and Cassidy, 
1999).  
In postmenopausal women, isoflavones exert a weak estrogenic action and hence could be 
exploited as a dietary alternative or supplement to hormone replacement therapy (Setchell 
and Cassidy, 1999; Duffy et al., 2003). Improved cognitive ability was observed in 
postmenopausal women after intake of soybean extract containing isoflavones. Two types of 
estrogenic receptors (ER-ǂ and ER-ǃ) are found in the brain. Isoflavones bind preferentially 
to ER-ǃ receptors, which play a role in cognitive function and are found in abundance in 
brain regions involved in cognition (Duffy et al., 2003). 
From the foregoing account it can be seen that isoflavones represent important bioactive 
components of soybean. In addition, protease inhibitors, lectins and antifungal proteins in 
soybean display a multiplicity of health promoting activities  such as antitumor, mitogenic 
and antimicrobial activities (Table 1). Hence the intake of soybean is beneficial to health. 
6. Conclusion  
The above review of literature has revealed that protease inhibitors in some cultivars of 
soybean have marked thermostability and pH stability and may account for the reduced 
incidence of cancer in populations favouring a diet rich in soybeans. Soybean saponins also 
may account for part of the antitumor activity in soybeans. Soybean saponins also display 
other health promoting effects such as anti-osteoporotic activity. Lectins and antifungal 
proteins also exhibit antitumor and other activities. Thus a regular dietary intake of 




Bioactive component s of soybean         Biological activities 
                      
Protease inhibitors                                  Antitumor, HIV-1 reverse transcriptase inhibitory 
(Bowman – Birk and Kunitz types) 
 
Lectin                                                        Antitumor, HIV-1 reverse transcriptase inhibitory 
 
Antifungal protein                                 Antifungal, HIV-1 reverse transcriptase inhibitory,  
                                                    anti-mitogenic 
 
Saponins                                                  Hypocholesterolemic , anti-atherosclerotic , increase  
                                                                  bone mineral density 
 
Table 1. Bioactive components of soybean and their biological activities  
www.intechopen.com
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